These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 24200798)

  • 1. Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability.
    Nishio S; Abe M; Ito H
    Diabetes Metab Syndr Obes; 2015; 8():163-71. PubMed ID: 25834461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with DPP-4I Anagliptin or α-GI Miglitol Reduces IGT Development and the Expression of CVD Risk Factors in OLETF Rats.
    Imai C; Harazaki T; Inoue S; Mochizuki K; Goda T
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(4):313-21. PubMed ID: 26440638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
    Mochizuki K; Fukaya N; Tanaka Y; Fuchigami M; Goda T
    Metabolism; 2011 Nov; 60(11):1560-5. PubMed ID: 21550076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1beta and tumour necrosis factor-alpha gene expression in rat peripheral leucocytes induced by intermittent sucrose loading.
    Tanaka Y; Mochizuki K; Fukaya N; Shimada M; Goda T
    Br J Nutr; 2009 Jul; 102(2):221-5. PubMed ID: 19138443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.
    Fukaya N; Mochizuki K; Tanaka Y; Kumazawa T; Jiuxin Z; Fuchigami M; Goda T
    Eur J Pharmacol; 2009 Dec; 624(1-3):51-7. PubMed ID: 19818342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of β2 integrin genes in rat peripheral leukocytes by inhibiting postprandial hyperglycemia.
    Mochizuki K; Shimada M; Tanaka Y; Fukaya N; Goda T
    Biosci Biotechnol Biochem; 2010; 74(12):2470-4. PubMed ID: 21150098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of postprandial hyperglycemia by either an insulin-dependent or -independent drug reduces the expression of genes related to inflammation in peripheral leukocytes of OLETF rats.
    Imai C; Harazaki T; Inoue S; Mochizuki K; Goda T
    Biosci Biotechnol Biochem; 2013; 77(11):2305-8. PubMed ID: 24200798
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.